Gene regulatory networks: a new conceptual framework to analyse breast cancer behaviour

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Annals of Oncology (Impact Factor: 6.58). 11/2010; 22(6):1259-65. DOI: 10.1093/annonc/mdq546
Source: PubMed

ABSTRACT The study of complex systems has clearly evidenced that a few overall behavioural properties cannot be inferred from the properties of their single parts and are rather determined by their architecture. Such an approach has been recently proposed in biology to understand genome functioning and in oncology to endeavour a more consistent explanation of the variegated cancer behaviours. In the present perspective, we summarise the basic concepts of the proposed global approach and then we reconsider, in this new context, tumour dormancy and primary tumour removal effects, which recently emerged as critical points for breast cancer understanding.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to construct the breast cancer gene regulatory networks through the high-throughput techniques and optimize the drug target genes of breast cancer using bioinformatics analysis, and thus accelerate the process of drug development and improve the cure rate of breast cancer. The gene expression profile data of breast cancer were downloaded from GEO database and the transcriptional regulation data were obtained from UCSC database. Then we identified the differentially expressed genes (DEGs) by SAM algorithm and built gene regulatory networks by the supervised algorithm SIRENE. Finally, the drug targets of the DEGs with changed regulation relations were optimized based on the CancerResource database. A total of 584 DEGs were identified and the gene regulatory networks in the normal state and tumorous state were constructed. By comparing the new predicted regulatory relation in cancer state and normal state, the regulatory relation of 18 genes was found to be changed in the two states, showing the possibility to be applied as drug target genes. After the searches in the CancerResources, 7 genes were screened as the drug target genes, such as PFKFB3. Our present findings shed new light on the molecular mechanism of breast cancer and provide some drug targets which have the potential to be used in clinic for the treatment of breast cancer in future.
    Archives of Gynecology and Obstetrics 06/2014; 290(4). DOI:10.1007/s00404-014-3264-y · 1.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dysregulation of transcriptional programs leads to cell malfunctioning and can have an impact in cancer development. Our study aims to characterize global differences between transcriptional regulatory programs of normal and tumor cells of the colon.
    BMC Cancer 09/2014; 14(1):708. DOI:10.1186/1471-2407-14-708 · 3.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gene regulatory networks (GRN)affect numerous cellular processes and every process of life, and abnormalities of GRN lead to breast cancer. Transcription factors (TF) and microRNAs (miRNA) are two of the best-studied gene regulatory mechanisms. However, the architecture and feature of GRNs by TFs and miRNAs in breast cancer and its subtypes were unknown. In this study, we investigated the GRNs by TFs and miRNAs with emphasis on breast cancer classifier genes (BCCGs) at system level.
    Bioinformatics 09/2014; DOI:10.1093/bioinformatics/btu597 · 4.62 Impact Factor